ADCYAP1 and migraine disorder: PACAP has shown to be involved in trigeminovascular activation as PACAP-38 infusion caused headache in healthy volunteers [39] and PACAP-38-like immunoreactivity has proved to be altered in ictal compared to interictal phase of migraine and in cluster headache [40, 41].